In-Vitro Diagnostics Global Market Report 2020-30: COVID-19 Implications and Growth from the publisher covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for in-vitro diagnostics which play a critical role to detect the COVID-19 virus.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the in-vitro diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-Vitro Diagnostics Market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider in-vitro diagnostics market, and compares it with other markets.
Scope
Markets Covered:
1) By Type: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc; Thermo Fisher Scientific Inc
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, in-vitro diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the in-vitro diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-Vitro Diagnostics Market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider in-vitro diagnostics market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The in-vitro diagnostics market section of the report gives context. It compares the in-vitro diagnostics market with other segments of the in-vitro diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, in-vitro diagnostics indicators comparison.
Scope
Markets Covered:
1) By Type: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc; Thermo Fisher Scientific Inc
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, in-vitro diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Report Structure7. In-Vitro Diagnostics Market Trends And Strategies20. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market24. Copyright And Disclaimer
3. In-Vitro Diagnostics Market Characteristics
4. In-Vitro Diagnostics Market Product Analysis
5. In-Vitro Diagnostics Market Supply Chain
6. In-Vitro Diagnostics Market Customer Information
8. In-Vitro Diagnostics Market Size And Growth
9. In-Vitro Diagnostics Market Regional Analysis
10. In-Vitro Diagnostics Market Segmentation
11. In-Vitro Diagnostics Market Metrics
12. Asia-Pacific In-Vitro Diagnostics Market
13. Western Europe In-Vitro Diagnostics Market
14. Eastern Europe In-Vitro Diagnostics Market
15. North America In-Vitro Diagnostics Market
16. South America In-Vitro Diagnostics Market
17. Middle East In-Vitro Diagnostics Market
18. Africa In-Vitro Diagnostics Market
19. In-Vitro Diagnostics Market Competitive Landscape
21. Market Background: Medical Equipment Market
22. Recommendations
23. Appendix
Executive Summary
North America was the largest region in the global in-vitro diagnostics market, accounting for 35% of the market in 2019. Asia Pacific was the second largest region accounting for 31% of the global in-vitro diagnostics market. Africa was the smallest region in the global in-vitro diagnostics market.Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks . In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space.
The in-vitro diagnostics devices (or) equipment manufacturing market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics. This industry includes establishments that produce diagnostic devices used in microbiological diagnosis, hematological diagnosis, molecular diagnosis, point of care diagnosis and others.
The global in-vitro diagnostics market is expected to grow from $57.9 billion in 2019 to $71.3 billion in 2020 at a compound annual growth rate (CAGR) of 23.2%. The growth of this market is mainly due to the increased diagnostic testing in laboratories, hospitals, and other testing sites across various country to detect the pandemic COVID-19 virus. The need for rapid diagnostic testing such as molecular and RT PCR based testing to identify people infected by coronavirus is driving the in-vitro diagnostics market. The market is then expected to stabilize and grow at a CAGR of 6% from 2021 and reach $81.3 billion in 2023.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Danaher (Beckman Coulter Inc)
- Abbott Laboratories Inc
- Thermo Fisher Scientific Inc
Methodology
LOADING...